AZ

Alex Zapesochny

North America, New York, United States, Rochester

Description

Alex Zapesochny is the CEO at Clerio Vision. He attended University of Cambridge.

Investor Profile

Alex Zapesochny has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series A (50%)
  • Series D (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alex Zapesochny frequently co-invest with?

UpVentures Capital
North America, New York, United States, Little Falls
Co-Investments: 2
SP
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Cranberry Capital
North America, New York, United States, Pittsford
Co-Investments: 1
Norwest Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 1
Armory Square Ventures
North America, New York, United States, Syracuse
Co-Investments: 2
Topmark Partners
North America, Florida, United States, Tampa
Co-Investments: 2

Which angels does Alex Zapesochny often collaborate with?

MT
North America, Nevada, United States, Stateline
Shared Deals: 2
AL
North America, New York, United States, Rochester
Shared Deals: 2

What are some of recent deals done by Alex Zapesochny?

Clerio Vision

Rochester, New York, United States

Clerio Vision is developing a revolutionary product platform for the global ophthalmic market.

BiotechnologyHealth CareMedicalMedical Device
Series DJul 10, 2019
Amount Raised: $11,934,846
Clerio Vision

Rochester, New York, United States

Clerio Vision is developing a revolutionary product platform for the global ophthalmic market.

BiotechnologyHealth CareMedicalMedical Device
Series AJan 13, 2015
Amount Raised: $3,725,000